19. DoE Introduction Core Knowledge (Engineering, Chemistry, Biology,…) Statistical Knowledge Develop Solutions DOE is NOT a replacement for process knowledge
20.
21.
22.
23.
24.
25. High Throughput Screening = 96 x Discreet variables- ‘The what” What is the best ligand/catalyst combination ? What is the best solvent ?
38. MK-518: Problem step Peter Maligres Existing Conditions : 4 eq Mg(OMe) 2 / 4 eq MeI @ 0.5 M (68% isolated yield) 18 solvents, 8 bases screened 78 22
39. MK-518: DOE Optimization Peter Maligres DOE Optimzation Design Factors : Mg(OMe) 2 equiv: 1.0 and 3.0 MeI equiv: 2.5 and 5.0 Conc: 0.25 and 1.0 M Temperature: 30 and 65 o C 19 reactions Responses (4 and 20 h): Assay yield Selectivity
40. MK-518 Optimization Peter Maligres DOE Optimal Settings Base equiv: 1.0 and 3.0 MeI equiv: 2.5 and 5.0 Temperature: 30 and 65 o C Conc: 0.25 and 1.0 M Time: 4 and 20 h 99 1
46. MK-518 Optimization Peter Maligres Yield =90% Selectivity = >99.9 % Safer, more economical reagents Incorporated best practices from DOE: HI Temp/HI Concentration/Longer reaction times
47. MK-518 Summary 78 22 > 99 < 1 DOE Goal of 20% reduction in drug inventory cost was achieved Higher Yield cascades back to allow fewer RM/solvents to be used Submitted for 2008 Presidential Green Chemistry Award
48.
49. Case Study 2- Suzuki DOE Factors : Ligand/Pd ratio: 1.0 and 3.0 Catalyst load: 0.1 and 0.5 mole% Molarity boronic acid: 0.5 and 1.5 Temperature: 60 and 80 o C 27 Reactions in 96-well plate format, 2 days to plan/setup/execute/assay 0.65 g material (24 mg/rxn) !!
50. Case Study 2- Suzuki DOE Optimal Settings : Ligand/Pd ratio: 1.0 and 3.0 Catalyst load: 0.1 and 0.5 mole% Molarity boronic acid : 0.5 and 1.5 Temperature: 60 and 80 o C ( 65 o C )
51. Effect of Temp and Pd Loading Lig/ catalyst ratio fixed at 3:1; Triol M fixed at 1.5 M Overall LCAP
52. Optimized Conditions Optimized Experiment: -increased LCAP by 1% -decreased DesBr impurity (50%) -decreased Pd by 75% -decreased Lig by 70% Spencer Dreher
53. Case Study #3 Dave Pollard Goal: to reduce cost by increasing productivity 100 g/L
54. Screening Design Dave Pollard Factors Octanol: 40 and 60 % NADP equiv: 0.1 and 0.5 % Concentration: 50 and 150 g/L Temp: 25 and 35 o C Enzyme load: 0.3 to 1.0 g/L 19 experiments
57. Screening Result Dave Pollard Factor Preferred Setting Octanol: 40 and 60 % No impact NADP equiv: 0.1 and 0.5 % No impact- increase more ? Concentration: 50 and 150 g/L 50 g/L- undesirable setting Temp: 25 and 35 o C minimal effect- set at 30 o C Enzyme load: 0.3 to 1.0 g/L 1.0 g/L- increase more
58. Optimization Design Dave Pollard Factor NADP equiv: 0.5 and 1.5 % Concentration: 100 and 200 g/L Enzyme load: 0.5 to 3.0 g/L 19 experiments
59. Optimization Design Factor Preferred setting NADP equiv: 0.5 and 1.5 % No effect Concentration: 100 and 200 g/L 200 Enzyme load: 0.5 to 3.0 g/L 3.0
60. Optimization Design Factor Preferred setting NADP equiv: 0.5 and 1.5 % No effect Concentration: 100 and 200 g/L 200 Enzyme load: 0.5 to 3.0 g/L 3.0 Confirming experiment at 200 g/L NADP= 0.5 g/L and enzyme at 3 g/L gave 100% conversion Goal achieved
69. Case Study # 5 Mark Weisel 10% loading Pearlman’s catalyst 25 o C/45 psi/EtOAc 88 A% Goal: to minimize formation of impurities/maximize desired product 12 A%
70. Case Study # 5 Mark Weisel 88 A% 12 A% DOE design: 4 Factors (19 reactions) Temp (25 and 55 o C) Pressure (30 and 60 psi) Pd(OH) 2 loading (5 and 15 wt%) Volume EtOAc (6 and 10 ml/g)
mature categories: anti-hypertensives/anti-biotics/cholesterol unmet needs: cancer/alzheimers/obesity mature therapies = anti-hypertensive, antibiotics……. protein-based drugs and vaccines have greater opportunities
Develop infrastructure in those countries
Fosamax-coming off patent this week. Feb 6 Insurers/benefits managers/consumers
Fosamax-coming off patent this week. Feb 6
Automation: not necessarily always a robot.- can be any tool that speeds up a workflow or allows a chemist to perform more value added tasks.
interaction = dependance of one factor on the setting of another
Statistical methods are tools used to make sense out of numbers. This slide illustrates the combination of statistical methods with your core knowledge. Statistical methods (specifically, designed experiments in today’s course) are a catalyst to science, NOT a substitute for it.
lead in to next slide: How to run the rxns ????
Existing experience using HTS
Here is the question we are now asking ourselves at Merck…..
Isentress generically known as Raltegravir. 1 st commercial HIV integrase inhibitor. Over 3 dozen people from process res